Deck 23: Neoplastic Disease

Full screen (f)
exit full mode
Question
All of the following are side effects of chemotherapy except:

A)neutropenia.
B)mucositis.
C)alopecia.
D)thrombosis.
Use Space or
up arrow
down arrow
to flip the card.
Question
A pt receiving RT to control intracranial swelling in order to alleviate pain is an example of:

A)palliative therapy.
B)neoadjuvant therapy.
C)salvage therapy.
D)primary therapy.
Question
Patients with cancer cachexia may experience muscle wasting due to:

A)hypercatabolism and/or decreased protein synthesis.
B)anorexia and/or nausea.
C)hypocatabolism and/or increased protein synthesis.
D)blood loss and/or hemorrhaging.
Question
The spinal accessory nerve helps control _____

A)swallowing, head and neck movement, and speech
B)swallowing, smell, and speech
C)breathing, smell, and head and neck movement
D)swallowing, breathing, and smell
Question
The selective neck dissection procedure involves the preservation of the:

A)hypoglossale nerve.
B)vagal nerve.
C)trigeminal nerve.
D)spinal accessory nerve.
Question
Which of the following is responsible for the transport and absorption of vitamin B12?

A)gastrin
B)HCl
C)intrinsic factor
D)pepsin
Question
Which of the following is an example of primary cancer prevention?

A)eating healthy and exercising
B)colorectal test
C)pap smear
D)endoscopy
Question
Pts with head and neck cancer often experience _____, which is due to their damaged or removed salivary glands

A)mucositis
B)dysphagia
C)xerostomia
D)dysuesia
Question
Barrett's esophagus, a risk factor for esophageal adenocarcinoma, is caused by:

A)gastrectomy.
B)gastroesophageal reflux disease.
C)esophagitis.
D)achlorhydria.
Question
Brachytherapy is used to treat all of the following except for:

A)prostate cancer.
B)cervical cancer.
C)pituitary cancer.
D)esophageal cancer.
Question
Which of the following cells is least sensitive to the effects of radiation?

A)epithelial cells
B)bone marrow cells
C)hepatic cells
D)hair follicles
Question
Which of the following is an example of secondary cancer prevention?

A)eating 5-9 servings of fruits and vegetables
B)smoking cessation
C)regular exercise
D)annual mammogram
Question
Tumors found in epithelial tissue are called:

A)adenomas.
B)sarcomas.
C)carcinomas.
D)gliomas.
Question
A pt undergoing chemotherapy is most likely going to experience GI problems because:

A)the chemotherapeutic agents are difficult to metabolize.
B)the chemotherapeutic agents are given systemically and affect the rapidly-dividing epithelial cells that line the GI system.
C)the chemotherapeutic agents cause an allergic reaction.
D)the chemotherapeutic agents are so strong they cause hemorrhaging.
Question
A partial or total gastrectomy increases a pt's risk for developing a deficiency of:

A)vitamin B12.
B)folic acid.
C)pantothenic acid.
D)vitamin B6.
Question
Tumor markers are used to detect a pt's response to tx For example, carcinoembryonic antigen is used to monitor:

A)prostate cancer.
B)breast cancer.
C)colon cancer.
D)ovarian cancer.
Question
What is the correct order of processes that take place when normal cells become cancer cells?

A)initiation, progression, promotion
B)initiation, promotion, progression
C)promotion, initiation, progression
D)promotion, progression, initiation
Question
The signs and symptoms of cancer cachexia include:

A)weight loss, muscle wasting, and anorexia.
B)insomnia, headaches, and vomiting.
C)diarrhea, muscle spasms, and cramping.
D)weight gain, slow metabolism, and delayed digestion.
Question
The reduced secretion of HCl due to the loss of parietal cells decreases the absorption of:

A)calcium and iron.
B)vitamin D and phosphorus.
C)vitamin C and zinc.
D)magnesium and selenium.
Question
RT destroys cancers cell by:

A)increasing the production of lysosomes.
B)altering DNA.
C)destroying the cell membrane.
D)decreasing the production of ribosomes.
Question
Which of the following is not an appropriate recommendation for a cancer patient who is experiencing nausea and vomiting?

A)eating small, frequent meals
B)administering prokinetics
C)avoiding noxious odors
D)cessation of antibiotics or pain medication
Question
All of the following are appropriate recommendations for a patient with mucositis except:

A)eat soft food.
B)avoid acidic foods and beverages.
C)eat non-fibrous foods.
D)drink hot coffee, tea, or soups.
Question
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
What is AS's percent IBW?

A)84%
B)103%
C)81%
D)91%
Question
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
How much body weight loss has ML experienced?

A)11.1%
B)10%
C)9.3%
D)8%
Question
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
How much body weight has AS lost?

A)30%
B)18%
C)22%
D)10%
Question
C-reactive protein is the most sensitive indicator for:

A)fluid status.
B)electrolyte balance.
C)nitrogen balance.
D)inflammation.
Question
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
All of the following might be of potential benefit in stabilizing AS's weight except:

A)oxandrolone
B)omega-3 fatty acids
C)enteral nutrition support
D)high-dose vitamins and minerals
Question
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
What percent of UBW is ML?

A)90%
B)134%
C)164%
D)87%
Question
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
If as a result of the chemotherapy, ML develops mucositis, what will the registered dietitian recommend?

A)additional lab work
B)oral arginine
C)drink at least two quarts a day of water
D)rinse with commercial mouthwash
Question
The primary goal of nutrition therapy for cancer patients is:

A)to ensure adequate micronutrient intake.
B)to ensure adequate intake of fluids.
C)to prevent malnutrition.
D)to increase caloric intake.
Question
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
The registered dietitian performs a nutrition assessment on AS He/She will use which of the following parameters to estimate AS's caloric requirements?

A)20-25 kcal/kg IBW
B)25-30 kcal/kg current body weight
C)30-35 kcal/kg current body weight
D)35-40 kcal/kg IBW
Question
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
The registered dietitian is consulted on ML's case because of his symptoms What is the goal of nutritional therapy at this time?

A)education on foods high in protein and fiber
B)prescribing antiemetics
C)preventing further weight loss
D)exploring ML's vitamin/mineral status
Question
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
Given the above, how would we feed this patient?

A)nasogastric tube
B)jejunostomy
C)nasoenteric tube
D)gastrostomy
Question
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
How would the registered dietitian calculate AS's protein needs?

A)0.8-1.0 g/kg
B)1.0-1.5 g/kg
C)1.5-2.5 g/kg
D)0.5-0.8 g/kg
Question
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
After performing a nutritional assessment on ML, the registered dietitian determines that he is at risk for what nutritional complication after surgery?

A)scar tissue obstructing the duodenum
B)complications with would healing
C)return of the cancer
D)delayed gastric emptying
Question
The nutrition-related side effects of administering high doses of corticosteroids to cancer patients include all of the following except:

A)dehydration.
B)hyperglycemia.
C)sodium retention.
D)nitrogen catabolism.
Question
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
Given the above numbers, the registered dietitian might diagnose AS with what?

A)failure to thrive
B)anorexia nervosa
C)cancer cachexia
D)underweight status
Question
Match between columns
salvage
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
salvage
a measure of the number of neutrophil granulocytes
salvage
a pharmacologic agent that reduces nausea
salvage
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
salvage
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
salvage
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
salvage
condition in which food moves too quickly from the stomach to the small intestine
salvage
altered taste
salvage
difficulty swallowing
salvage
difficulty speaking
salvage
an agent that causes nausea and/or vomiting
salvage
inflammation of a mucous membrane
salvage
the lowest point
salvage
refers to chemotherapy used prior to primary treatment
salvage
low white blood cell count
salvage
painful swallowing
salvage
a non-curative treatment which reduces symptoms such as pain
salvage
a prediction of the probable course and outcome of a disease
salvage
a pharmacologic agent that promotes gastric emptying
salvage
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
salvage
fat malabsorption resulting in severe diarrhea
salvage
refers to a condition or disease for which there is no cure
salvage
dry mouth
dysphagia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
dysphagia
a measure of the number of neutrophil granulocytes
dysphagia
a pharmacologic agent that reduces nausea
dysphagia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
dysphagia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
dysphagia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
dysphagia
condition in which food moves too quickly from the stomach to the small intestine
dysphagia
altered taste
dysphagia
difficulty swallowing
dysphagia
difficulty speaking
dysphagia
an agent that causes nausea and/or vomiting
dysphagia
inflammation of a mucous membrane
dysphagia
the lowest point
dysphagia
refers to chemotherapy used prior to primary treatment
dysphagia
low white blood cell count
dysphagia
painful swallowing
dysphagia
a non-curative treatment which reduces symptoms such as pain
dysphagia
a prediction of the probable course and outcome of a disease
dysphagia
a pharmacologic agent that promotes gastric emptying
dysphagia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
dysphagia
fat malabsorption resulting in severe diarrhea
dysphagia
refers to a condition or disease for which there is no cure
dysphagia
dry mouth
neoadjuvant chemotherapy
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
neoadjuvant chemotherapy
a measure of the number of neutrophil granulocytes
neoadjuvant chemotherapy
a pharmacologic agent that reduces nausea
neoadjuvant chemotherapy
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
neoadjuvant chemotherapy
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
neoadjuvant chemotherapy
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
neoadjuvant chemotherapy
condition in which food moves too quickly from the stomach to the small intestine
neoadjuvant chemotherapy
altered taste
neoadjuvant chemotherapy
difficulty swallowing
neoadjuvant chemotherapy
difficulty speaking
neoadjuvant chemotherapy
an agent that causes nausea and/or vomiting
neoadjuvant chemotherapy
inflammation of a mucous membrane
neoadjuvant chemotherapy
the lowest point
neoadjuvant chemotherapy
refers to chemotherapy used prior to primary treatment
neoadjuvant chemotherapy
low white blood cell count
neoadjuvant chemotherapy
painful swallowing
neoadjuvant chemotherapy
a non-curative treatment which reduces symptoms such as pain
neoadjuvant chemotherapy
a prediction of the probable course and outcome of a disease
neoadjuvant chemotherapy
a pharmacologic agent that promotes gastric emptying
neoadjuvant chemotherapy
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
neoadjuvant chemotherapy
fat malabsorption resulting in severe diarrhea
neoadjuvant chemotherapy
refers to a condition or disease for which there is no cure
neoadjuvant chemotherapy
dry mouth
prognosis
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
prognosis
a measure of the number of neutrophil granulocytes
prognosis
a pharmacologic agent that reduces nausea
prognosis
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
prognosis
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
prognosis
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
prognosis
condition in which food moves too quickly from the stomach to the small intestine
prognosis
altered taste
prognosis
difficulty swallowing
prognosis
difficulty speaking
prognosis
an agent that causes nausea and/or vomiting
prognosis
inflammation of a mucous membrane
prognosis
the lowest point
prognosis
refers to chemotherapy used prior to primary treatment
prognosis
low white blood cell count
prognosis
painful swallowing
prognosis
a non-curative treatment which reduces symptoms such as pain
prognosis
a prediction of the probable course and outcome of a disease
prognosis
a pharmacologic agent that promotes gastric emptying
prognosis
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
prognosis
fat malabsorption resulting in severe diarrhea
prognosis
refers to a condition or disease for which there is no cure
prognosis
dry mouth
Barrett's esophagus
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
Barrett's esophagus
a measure of the number of neutrophil granulocytes
Barrett's esophagus
a pharmacologic agent that reduces nausea
Barrett's esophagus
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
Barrett's esophagus
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
Barrett's esophagus
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
Barrett's esophagus
condition in which food moves too quickly from the stomach to the small intestine
Barrett's esophagus
altered taste
Barrett's esophagus
difficulty swallowing
Barrett's esophagus
difficulty speaking
Barrett's esophagus
an agent that causes nausea and/or vomiting
Barrett's esophagus
inflammation of a mucous membrane
Barrett's esophagus
the lowest point
Barrett's esophagus
refers to chemotherapy used prior to primary treatment
Barrett's esophagus
low white blood cell count
Barrett's esophagus
painful swallowing
Barrett's esophagus
a non-curative treatment which reduces symptoms such as pain
Barrett's esophagus
a prediction of the probable course and outcome of a disease
Barrett's esophagus
a pharmacologic agent that promotes gastric emptying
Barrett's esophagus
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
Barrett's esophagus
fat malabsorption resulting in severe diarrhea
Barrett's esophagus
refers to a condition or disease for which there is no cure
Barrett's esophagus
dry mouth
mucositis
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
mucositis
a measure of the number of neutrophil granulocytes
mucositis
a pharmacologic agent that reduces nausea
mucositis
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
mucositis
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
mucositis
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
mucositis
condition in which food moves too quickly from the stomach to the small intestine
mucositis
altered taste
mucositis
difficulty swallowing
mucositis
difficulty speaking
mucositis
an agent that causes nausea and/or vomiting
mucositis
inflammation of a mucous membrane
mucositis
the lowest point
mucositis
refers to chemotherapy used prior to primary treatment
mucositis
low white blood cell count
mucositis
painful swallowing
mucositis
a non-curative treatment which reduces symptoms such as pain
mucositis
a prediction of the probable course and outcome of a disease
mucositis
a pharmacologic agent that promotes gastric emptying
mucositis
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
mucositis
fat malabsorption resulting in severe diarrhea
mucositis
refers to a condition or disease for which there is no cure
mucositis
dry mouth
prokinetic
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
prokinetic
a measure of the number of neutrophil granulocytes
prokinetic
a pharmacologic agent that reduces nausea
prokinetic
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
prokinetic
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
prokinetic
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
prokinetic
condition in which food moves too quickly from the stomach to the small intestine
prokinetic
altered taste
prokinetic
difficulty swallowing
prokinetic
difficulty speaking
prokinetic
an agent that causes nausea and/or vomiting
prokinetic
inflammation of a mucous membrane
prokinetic
the lowest point
prokinetic
refers to chemotherapy used prior to primary treatment
prokinetic
low white blood cell count
prokinetic
painful swallowing
prokinetic
a non-curative treatment which reduces symptoms such as pain
prokinetic
a prediction of the probable course and outcome of a disease
prokinetic
a pharmacologic agent that promotes gastric emptying
prokinetic
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
prokinetic
fat malabsorption resulting in severe diarrhea
prokinetic
refers to a condition or disease for which there is no cure
prokinetic
dry mouth
brachytherapy
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
brachytherapy
a measure of the number of neutrophil granulocytes
brachytherapy
a pharmacologic agent that reduces nausea
brachytherapy
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
brachytherapy
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
brachytherapy
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
brachytherapy
condition in which food moves too quickly from the stomach to the small intestine
brachytherapy
altered taste
brachytherapy
difficulty swallowing
brachytherapy
difficulty speaking
brachytherapy
an agent that causes nausea and/or vomiting
brachytherapy
inflammation of a mucous membrane
brachytherapy
the lowest point
brachytherapy
refers to chemotherapy used prior to primary treatment
brachytherapy
low white blood cell count
brachytherapy
painful swallowing
brachytherapy
a non-curative treatment which reduces symptoms such as pain
brachytherapy
a prediction of the probable course and outcome of a disease
brachytherapy
a pharmacologic agent that promotes gastric emptying
brachytherapy
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
brachytherapy
fat malabsorption resulting in severe diarrhea
brachytherapy
refers to a condition or disease for which there is no cure
brachytherapy
dry mouth
combination chemotherapy
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
combination chemotherapy
a measure of the number of neutrophil granulocytes
combination chemotherapy
a pharmacologic agent that reduces nausea
combination chemotherapy
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
combination chemotherapy
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
combination chemotherapy
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
combination chemotherapy
condition in which food moves too quickly from the stomach to the small intestine
combination chemotherapy
altered taste
combination chemotherapy
difficulty swallowing
combination chemotherapy
difficulty speaking
combination chemotherapy
an agent that causes nausea and/or vomiting
combination chemotherapy
inflammation of a mucous membrane
combination chemotherapy
the lowest point
combination chemotherapy
refers to chemotherapy used prior to primary treatment
combination chemotherapy
low white blood cell count
combination chemotherapy
painful swallowing
combination chemotherapy
a non-curative treatment which reduces symptoms such as pain
combination chemotherapy
a prediction of the probable course and outcome of a disease
combination chemotherapy
a pharmacologic agent that promotes gastric emptying
combination chemotherapy
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
combination chemotherapy
fat malabsorption resulting in severe diarrhea
combination chemotherapy
refers to a condition or disease for which there is no cure
combination chemotherapy
dry mouth
antiemetic
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
antiemetic
a measure of the number of neutrophil granulocytes
antiemetic
a pharmacologic agent that reduces nausea
antiemetic
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
antiemetic
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
antiemetic
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
antiemetic
condition in which food moves too quickly from the stomach to the small intestine
antiemetic
altered taste
antiemetic
difficulty swallowing
antiemetic
difficulty speaking
antiemetic
an agent that causes nausea and/or vomiting
antiemetic
inflammation of a mucous membrane
antiemetic
the lowest point
antiemetic
refers to chemotherapy used prior to primary treatment
antiemetic
low white blood cell count
antiemetic
painful swallowing
antiemetic
a non-curative treatment which reduces symptoms such as pain
antiemetic
a prediction of the probable course and outcome of a disease
antiemetic
a pharmacologic agent that promotes gastric emptying
antiemetic
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
antiemetic
fat malabsorption resulting in severe diarrhea
antiemetic
refers to a condition or disease for which there is no cure
antiemetic
dry mouth
terminal
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
terminal
a measure of the number of neutrophil granulocytes
terminal
a pharmacologic agent that reduces nausea
terminal
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
terminal
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
terminal
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
terminal
condition in which food moves too quickly from the stomach to the small intestine
terminal
altered taste
terminal
difficulty swallowing
terminal
difficulty speaking
terminal
an agent that causes nausea and/or vomiting
terminal
inflammation of a mucous membrane
terminal
the lowest point
terminal
refers to chemotherapy used prior to primary treatment
terminal
low white blood cell count
terminal
painful swallowing
terminal
a non-curative treatment which reduces symptoms such as pain
terminal
a prediction of the probable course and outcome of a disease
terminal
a pharmacologic agent that promotes gastric emptying
terminal
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
terminal
fat malabsorption resulting in severe diarrhea
terminal
refers to a condition or disease for which there is no cure
terminal
dry mouth
neutropenia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
neutropenia
a measure of the number of neutrophil granulocytes
neutropenia
a pharmacologic agent that reduces nausea
neutropenia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
neutropenia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
neutropenia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
neutropenia
condition in which food moves too quickly from the stomach to the small intestine
neutropenia
altered taste
neutropenia
difficulty swallowing
neutropenia
difficulty speaking
neutropenia
an agent that causes nausea and/or vomiting
neutropenia
inflammation of a mucous membrane
neutropenia
the lowest point
neutropenia
refers to chemotherapy used prior to primary treatment
neutropenia
low white blood cell count
neutropenia
painful swallowing
neutropenia
a non-curative treatment which reduces symptoms such as pain
neutropenia
a prediction of the probable course and outcome of a disease
neutropenia
a pharmacologic agent that promotes gastric emptying
neutropenia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
neutropenia
fat malabsorption resulting in severe diarrhea
neutropenia
refers to a condition or disease for which there is no cure
neutropenia
dry mouth
palliative
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
palliative
a measure of the number of neutrophil granulocytes
palliative
a pharmacologic agent that reduces nausea
palliative
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
palliative
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
palliative
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
palliative
condition in which food moves too quickly from the stomach to the small intestine
palliative
altered taste
palliative
difficulty swallowing
palliative
difficulty speaking
palliative
an agent that causes nausea and/or vomiting
palliative
inflammation of a mucous membrane
palliative
the lowest point
palliative
refers to chemotherapy used prior to primary treatment
palliative
low white blood cell count
palliative
painful swallowing
palliative
a non-curative treatment which reduces symptoms such as pain
palliative
a prediction of the probable course and outcome of a disease
palliative
a pharmacologic agent that promotes gastric emptying
palliative
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
palliative
fat malabsorption resulting in severe diarrhea
palliative
refers to a condition or disease for which there is no cure
palliative
dry mouth
xerostomia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
xerostomia
a measure of the number of neutrophil granulocytes
xerostomia
a pharmacologic agent that reduces nausea
xerostomia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
xerostomia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
xerostomia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
xerostomia
condition in which food moves too quickly from the stomach to the small intestine
xerostomia
altered taste
xerostomia
difficulty swallowing
xerostomia
difficulty speaking
xerostomia
an agent that causes nausea and/or vomiting
xerostomia
inflammation of a mucous membrane
xerostomia
the lowest point
xerostomia
refers to chemotherapy used prior to primary treatment
xerostomia
low white blood cell count
xerostomia
painful swallowing
xerostomia
a non-curative treatment which reduces symptoms such as pain
xerostomia
a prediction of the probable course and outcome of a disease
xerostomia
a pharmacologic agent that promotes gastric emptying
xerostomia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
xerostomia
fat malabsorption resulting in severe diarrhea
xerostomia
refers to a condition or disease for which there is no cure
xerostomia
dry mouth
steatorrhea
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
steatorrhea
a measure of the number of neutrophil granulocytes
steatorrhea
a pharmacologic agent that reduces nausea
steatorrhea
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
steatorrhea
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
steatorrhea
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
steatorrhea
condition in which food moves too quickly from the stomach to the small intestine
steatorrhea
altered taste
steatorrhea
difficulty swallowing
steatorrhea
difficulty speaking
steatorrhea
an agent that causes nausea and/or vomiting
steatorrhea
inflammation of a mucous membrane
steatorrhea
the lowest point
steatorrhea
refers to chemotherapy used prior to primary treatment
steatorrhea
low white blood cell count
steatorrhea
painful swallowing
steatorrhea
a non-curative treatment which reduces symptoms such as pain
steatorrhea
a prediction of the probable course and outcome of a disease
steatorrhea
a pharmacologic agent that promotes gastric emptying
steatorrhea
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
steatorrhea
fat malabsorption resulting in severe diarrhea
steatorrhea
refers to a condition or disease for which there is no cure
steatorrhea
dry mouth
dumping syndrome
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
dumping syndrome
a measure of the number of neutrophil granulocytes
dumping syndrome
a pharmacologic agent that reduces nausea
dumping syndrome
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
dumping syndrome
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
dumping syndrome
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
dumping syndrome
condition in which food moves too quickly from the stomach to the small intestine
dumping syndrome
altered taste
dumping syndrome
difficulty swallowing
dumping syndrome
difficulty speaking
dumping syndrome
an agent that causes nausea and/or vomiting
dumping syndrome
inflammation of a mucous membrane
dumping syndrome
the lowest point
dumping syndrome
refers to chemotherapy used prior to primary treatment
dumping syndrome
low white blood cell count
dumping syndrome
painful swallowing
dumping syndrome
a non-curative treatment which reduces symptoms such as pain
dumping syndrome
a prediction of the probable course and outcome of a disease
dumping syndrome
a pharmacologic agent that promotes gastric emptying
dumping syndrome
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
dumping syndrome
fat malabsorption resulting in severe diarrhea
dumping syndrome
refers to a condition or disease for which there is no cure
dumping syndrome
dry mouth
dysphonia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
dysphonia
a measure of the number of neutrophil granulocytes
dysphonia
a pharmacologic agent that reduces nausea
dysphonia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
dysphonia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
dysphonia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
dysphonia
condition in which food moves too quickly from the stomach to the small intestine
dysphonia
altered taste
dysphonia
difficulty swallowing
dysphonia
difficulty speaking
dysphonia
an agent that causes nausea and/or vomiting
dysphonia
inflammation of a mucous membrane
dysphonia
the lowest point
dysphonia
refers to chemotherapy used prior to primary treatment
dysphonia
low white blood cell count
dysphonia
painful swallowing
dysphonia
a non-curative treatment which reduces symptoms such as pain
dysphonia
a prediction of the probable course and outcome of a disease
dysphonia
a pharmacologic agent that promotes gastric emptying
dysphonia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
dysphonia
fat malabsorption resulting in severe diarrhea
dysphonia
refers to a condition or disease for which there is no cure
dysphonia
dry mouth
emetogenic
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
emetogenic
a measure of the number of neutrophil granulocytes
emetogenic
a pharmacologic agent that reduces nausea
emetogenic
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
emetogenic
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
emetogenic
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
emetogenic
condition in which food moves too quickly from the stomach to the small intestine
emetogenic
altered taste
emetogenic
difficulty swallowing
emetogenic
difficulty speaking
emetogenic
an agent that causes nausea and/or vomiting
emetogenic
inflammation of a mucous membrane
emetogenic
the lowest point
emetogenic
refers to chemotherapy used prior to primary treatment
emetogenic
low white blood cell count
emetogenic
painful swallowing
emetogenic
a non-curative treatment which reduces symptoms such as pain
emetogenic
a prediction of the probable course and outcome of a disease
emetogenic
a pharmacologic agent that promotes gastric emptying
emetogenic
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
emetogenic
fat malabsorption resulting in severe diarrhea
emetogenic
refers to a condition or disease for which there is no cure
emetogenic
dry mouth
adjuvant chemotherapy
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
adjuvant chemotherapy
a measure of the number of neutrophil granulocytes
adjuvant chemotherapy
a pharmacologic agent that reduces nausea
adjuvant chemotherapy
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
adjuvant chemotherapy
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
adjuvant chemotherapy
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
adjuvant chemotherapy
condition in which food moves too quickly from the stomach to the small intestine
adjuvant chemotherapy
altered taste
adjuvant chemotherapy
difficulty swallowing
adjuvant chemotherapy
difficulty speaking
adjuvant chemotherapy
an agent that causes nausea and/or vomiting
adjuvant chemotherapy
inflammation of a mucous membrane
adjuvant chemotherapy
the lowest point
adjuvant chemotherapy
refers to chemotherapy used prior to primary treatment
adjuvant chemotherapy
low white blood cell count
adjuvant chemotherapy
painful swallowing
adjuvant chemotherapy
a non-curative treatment which reduces symptoms such as pain
adjuvant chemotherapy
a prediction of the probable course and outcome of a disease
adjuvant chemotherapy
a pharmacologic agent that promotes gastric emptying
adjuvant chemotherapy
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
adjuvant chemotherapy
fat malabsorption resulting in severe diarrhea
adjuvant chemotherapy
refers to a condition or disease for which there is no cure
adjuvant chemotherapy
dry mouth
ANC
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
ANC
a measure of the number of neutrophil granulocytes
ANC
a pharmacologic agent that reduces nausea
ANC
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
ANC
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
ANC
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
ANC
condition in which food moves too quickly from the stomach to the small intestine
ANC
altered taste
ANC
difficulty swallowing
ANC
difficulty speaking
ANC
an agent that causes nausea and/or vomiting
ANC
inflammation of a mucous membrane
ANC
the lowest point
ANC
refers to chemotherapy used prior to primary treatment
ANC
low white blood cell count
ANC
painful swallowing
ANC
a non-curative treatment which reduces symptoms such as pain
ANC
a prediction of the probable course and outcome of a disease
ANC
a pharmacologic agent that promotes gastric emptying
ANC
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
ANC
fat malabsorption resulting in severe diarrhea
ANC
refers to a condition or disease for which there is no cure
ANC
dry mouth
nadir
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
nadir
a measure of the number of neutrophil granulocytes
nadir
a pharmacologic agent that reduces nausea
nadir
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
nadir
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
nadir
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
nadir
condition in which food moves too quickly from the stomach to the small intestine
nadir
altered taste
nadir
difficulty swallowing
nadir
difficulty speaking
nadir
an agent that causes nausea and/or vomiting
nadir
inflammation of a mucous membrane
nadir
the lowest point
nadir
refers to chemotherapy used prior to primary treatment
nadir
low white blood cell count
nadir
painful swallowing
nadir
a non-curative treatment which reduces symptoms such as pain
nadir
a prediction of the probable course and outcome of a disease
nadir
a pharmacologic agent that promotes gastric emptying
nadir
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
nadir
fat malabsorption resulting in severe diarrhea
nadir
refers to a condition or disease for which there is no cure
nadir
dry mouth
dysgeusia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
dysgeusia
a measure of the number of neutrophil granulocytes
dysgeusia
a pharmacologic agent that reduces nausea
dysgeusia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
dysgeusia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
dysgeusia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
dysgeusia
condition in which food moves too quickly from the stomach to the small intestine
dysgeusia
altered taste
dysgeusia
difficulty swallowing
dysgeusia
difficulty speaking
dysgeusia
an agent that causes nausea and/or vomiting
dysgeusia
inflammation of a mucous membrane
dysgeusia
the lowest point
dysgeusia
refers to chemotherapy used prior to primary treatment
dysgeusia
low white blood cell count
dysgeusia
painful swallowing
dysgeusia
a non-curative treatment which reduces symptoms such as pain
dysgeusia
a prediction of the probable course and outcome of a disease
dysgeusia
a pharmacologic agent that promotes gastric emptying
dysgeusia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
dysgeusia
fat malabsorption resulting in severe diarrhea
dysgeusia
refers to a condition or disease for which there is no cure
dysgeusia
dry mouth
odynophagia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
odynophagia
a measure of the number of neutrophil granulocytes
odynophagia
a pharmacologic agent that reduces nausea
odynophagia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
odynophagia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
odynophagia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
odynophagia
condition in which food moves too quickly from the stomach to the small intestine
odynophagia
altered taste
odynophagia
difficulty swallowing
odynophagia
difficulty speaking
odynophagia
an agent that causes nausea and/or vomiting
odynophagia
inflammation of a mucous membrane
odynophagia
the lowest point
odynophagia
refers to chemotherapy used prior to primary treatment
odynophagia
low white blood cell count
odynophagia
painful swallowing
odynophagia
a non-curative treatment which reduces symptoms such as pain
odynophagia
a prediction of the probable course and outcome of a disease
odynophagia
a pharmacologic agent that promotes gastric emptying
odynophagia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
odynophagia
fat malabsorption resulting in severe diarrhea
odynophagia
refers to a condition or disease for which there is no cure
odynophagia
dry mouth
Unlock Deck
Sign up to unlock the cards in this deck!
Unlock Deck
Unlock Deck
1/38
auto play flashcards
Play
simple tutorial
Full screen (f)
exit full mode
Deck 23: Neoplastic Disease
1
All of the following are side effects of chemotherapy except:

A)neutropenia.
B)mucositis.
C)alopecia.
D)thrombosis.
D
2
A pt receiving RT to control intracranial swelling in order to alleviate pain is an example of:

A)palliative therapy.
B)neoadjuvant therapy.
C)salvage therapy.
D)primary therapy.
A
3
Patients with cancer cachexia may experience muscle wasting due to:

A)hypercatabolism and/or decreased protein synthesis.
B)anorexia and/or nausea.
C)hypocatabolism and/or increased protein synthesis.
D)blood loss and/or hemorrhaging.
A
4
The spinal accessory nerve helps control _____

A)swallowing, head and neck movement, and speech
B)swallowing, smell, and speech
C)breathing, smell, and head and neck movement
D)swallowing, breathing, and smell
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
5
The selective neck dissection procedure involves the preservation of the:

A)hypoglossale nerve.
B)vagal nerve.
C)trigeminal nerve.
D)spinal accessory nerve.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
6
Which of the following is responsible for the transport and absorption of vitamin B12?

A)gastrin
B)HCl
C)intrinsic factor
D)pepsin
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
7
Which of the following is an example of primary cancer prevention?

A)eating healthy and exercising
B)colorectal test
C)pap smear
D)endoscopy
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
8
Pts with head and neck cancer often experience _____, which is due to their damaged or removed salivary glands

A)mucositis
B)dysphagia
C)xerostomia
D)dysuesia
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
9
Barrett's esophagus, a risk factor for esophageal adenocarcinoma, is caused by:

A)gastrectomy.
B)gastroesophageal reflux disease.
C)esophagitis.
D)achlorhydria.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
10
Brachytherapy is used to treat all of the following except for:

A)prostate cancer.
B)cervical cancer.
C)pituitary cancer.
D)esophageal cancer.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
11
Which of the following cells is least sensitive to the effects of radiation?

A)epithelial cells
B)bone marrow cells
C)hepatic cells
D)hair follicles
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
12
Which of the following is an example of secondary cancer prevention?

A)eating 5-9 servings of fruits and vegetables
B)smoking cessation
C)regular exercise
D)annual mammogram
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
13
Tumors found in epithelial tissue are called:

A)adenomas.
B)sarcomas.
C)carcinomas.
D)gliomas.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
14
A pt undergoing chemotherapy is most likely going to experience GI problems because:

A)the chemotherapeutic agents are difficult to metabolize.
B)the chemotherapeutic agents are given systemically and affect the rapidly-dividing epithelial cells that line the GI system.
C)the chemotherapeutic agents cause an allergic reaction.
D)the chemotherapeutic agents are so strong they cause hemorrhaging.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
15
A partial or total gastrectomy increases a pt's risk for developing a deficiency of:

A)vitamin B12.
B)folic acid.
C)pantothenic acid.
D)vitamin B6.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
16
Tumor markers are used to detect a pt's response to tx For example, carcinoembryonic antigen is used to monitor:

A)prostate cancer.
B)breast cancer.
C)colon cancer.
D)ovarian cancer.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
17
What is the correct order of processes that take place when normal cells become cancer cells?

A)initiation, progression, promotion
B)initiation, promotion, progression
C)promotion, initiation, progression
D)promotion, progression, initiation
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
18
The signs and symptoms of cancer cachexia include:

A)weight loss, muscle wasting, and anorexia.
B)insomnia, headaches, and vomiting.
C)diarrhea, muscle spasms, and cramping.
D)weight gain, slow metabolism, and delayed digestion.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
19
The reduced secretion of HCl due to the loss of parietal cells decreases the absorption of:

A)calcium and iron.
B)vitamin D and phosphorus.
C)vitamin C and zinc.
D)magnesium and selenium.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
20
RT destroys cancers cell by:

A)increasing the production of lysosomes.
B)altering DNA.
C)destroying the cell membrane.
D)decreasing the production of ribosomes.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
21
Which of the following is not an appropriate recommendation for a cancer patient who is experiencing nausea and vomiting?

A)eating small, frequent meals
B)administering prokinetics
C)avoiding noxious odors
D)cessation of antibiotics or pain medication
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
22
All of the following are appropriate recommendations for a patient with mucositis except:

A)eat soft food.
B)avoid acidic foods and beverages.
C)eat non-fibrous foods.
D)drink hot coffee, tea, or soups.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
23
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
What is AS's percent IBW?

A)84%
B)103%
C)81%
D)91%
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
24
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
How much body weight loss has ML experienced?

A)11.1%
B)10%
C)9.3%
D)8%
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
25
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
How much body weight has AS lost?

A)30%
B)18%
C)22%
D)10%
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
26
C-reactive protein is the most sensitive indicator for:

A)fluid status.
B)electrolyte balance.
C)nitrogen balance.
D)inflammation.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
27
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
All of the following might be of potential benefit in stabilizing AS's weight except:

A)oxandrolone
B)omega-3 fatty acids
C)enteral nutrition support
D)high-dose vitamins and minerals
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
28
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
What percent of UBW is ML?

A)90%
B)134%
C)164%
D)87%
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
29
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
If as a result of the chemotherapy, ML develops mucositis, what will the registered dietitian recommend?

A)additional lab work
B)oral arginine
C)drink at least two quarts a day of water
D)rinse with commercial mouthwash
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
30
The primary goal of nutrition therapy for cancer patients is:

A)to ensure adequate micronutrient intake.
B)to ensure adequate intake of fluids.
C)to prevent malnutrition.
D)to increase caloric intake.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
31
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
The registered dietitian performs a nutrition assessment on AS He/She will use which of the following parameters to estimate AS's caloric requirements?

A)20-25 kcal/kg IBW
B)25-30 kcal/kg current body weight
C)30-35 kcal/kg current body weight
D)35-40 kcal/kg IBW
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
32
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
The registered dietitian is consulted on ML's case because of his symptoms What is the goal of nutritional therapy at this time?

A)education on foods high in protein and fiber
B)prescribing antiemetics
C)preventing further weight loss
D)exploring ML's vitamin/mineral status
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
33
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
Given the above, how would we feed this patient?

A)nasogastric tube
B)jejunostomy
C)nasoenteric tube
D)gastrostomy
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
34
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
How would the registered dietitian calculate AS's protein needs?

A)0.8-1.0 g/kg
B)1.0-1.5 g/kg
C)1.5-2.5 g/kg
D)0.5-0.8 g/kg
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
35
Case Study Multiple Choice
ML is 55-year-old white male with prior medical hx of hyperlipidemia and DM.His mother died at the age of 60 from colon cancer.During the last 4 weeks he has had symptoms of abdominal pain, he feels weak and fatigued, more and more often he feels his back ache, and he has noticed darkening of his urine and lighter-in-color stools.Also, he reports having episodes of nausea and vomiting and has lost his appetite.ML has been losing weight during the last 5 weeks.All these symptoms led him to his doctor, who ordered a laboratory analysis.
The doctor ordered a computed tomography (CT) and an ultrasound.To confirm diagnosis a biopsy was also performed.ML was diagnosed with ductal adenocarcinoma of the head of the pancreas Stage III.
Height: 5'7" Weight: 198# UBW: 220#
The doctor ordered the administration of chemotherapy with 5-Fluorouracil (5-FU) and improvement of his nutritional condition before surgery (Whipple procedure).Other meds prescribed: Zofran, Duragesic, pancrealipase, regular insulin.
Diet Order: NPO
After performing a nutritional assessment on ML, the registered dietitian determines that he is at risk for what nutritional complication after surgery?

A)scar tissue obstructing the duodenum
B)complications with would healing
C)return of the cancer
D)delayed gastric emptying
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
36
The nutrition-related side effects of administering high doses of corticosteroids to cancer patients include all of the following except:

A)dehydration.
B)hyperglycemia.
C)sodium retention.
D)nitrogen catabolism.
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
37
AS is a 54 yo business man who has a family history of lung cancer.AS started smoking at 15; years later, he got what he thought was a very bad cold that lasted for a week, started experiencing pain in his tongue, and was given ibuprofen for pain.He then noticed white sores that were getting bigger in his oral cavity near the tongue.He started feeling generally lousy and was unable to eat due to severe pain, and lost 30 lbs in a month.AS went to the clinic, where they did a biopsy that revealed squamous cell cancer of the oral tongue.AS has undergone RT and surgery to remove the cancer and a restorative surgery was scheduled.Due to RT, AS has developed mucositis and xerostomia in his oral cavity.All his nodes that were sent to the laboratory tested negative for metastasis, and no further RT was needed.The surgeons felt confident that they had removed all the cancer.
HT: 5`9" UBW: 165 lbs WT: 135 lbs
Meds: Corticosteroids; antineoplastic (dexamethasone) to reduce inflammation, K depletion, Na retention; and morphine for pain.
Given the above numbers, the registered dietitian might diagnose AS with what?

A)failure to thrive
B)anorexia nervosa
C)cancer cachexia
D)underweight status
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
38
Match between columns
salvage
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
salvage
a measure of the number of neutrophil granulocytes
salvage
a pharmacologic agent that reduces nausea
salvage
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
salvage
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
salvage
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
salvage
condition in which food moves too quickly from the stomach to the small intestine
salvage
altered taste
salvage
difficulty swallowing
salvage
difficulty speaking
salvage
an agent that causes nausea and/or vomiting
salvage
inflammation of a mucous membrane
salvage
the lowest point
salvage
refers to chemotherapy used prior to primary treatment
salvage
low white blood cell count
salvage
painful swallowing
salvage
a non-curative treatment which reduces symptoms such as pain
salvage
a prediction of the probable course and outcome of a disease
salvage
a pharmacologic agent that promotes gastric emptying
salvage
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
salvage
fat malabsorption resulting in severe diarrhea
salvage
refers to a condition or disease for which there is no cure
salvage
dry mouth
dysphagia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
dysphagia
a measure of the number of neutrophil granulocytes
dysphagia
a pharmacologic agent that reduces nausea
dysphagia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
dysphagia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
dysphagia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
dysphagia
condition in which food moves too quickly from the stomach to the small intestine
dysphagia
altered taste
dysphagia
difficulty swallowing
dysphagia
difficulty speaking
dysphagia
an agent that causes nausea and/or vomiting
dysphagia
inflammation of a mucous membrane
dysphagia
the lowest point
dysphagia
refers to chemotherapy used prior to primary treatment
dysphagia
low white blood cell count
dysphagia
painful swallowing
dysphagia
a non-curative treatment which reduces symptoms such as pain
dysphagia
a prediction of the probable course and outcome of a disease
dysphagia
a pharmacologic agent that promotes gastric emptying
dysphagia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
dysphagia
fat malabsorption resulting in severe diarrhea
dysphagia
refers to a condition or disease for which there is no cure
dysphagia
dry mouth
neoadjuvant chemotherapy
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
neoadjuvant chemotherapy
a measure of the number of neutrophil granulocytes
neoadjuvant chemotherapy
a pharmacologic agent that reduces nausea
neoadjuvant chemotherapy
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
neoadjuvant chemotherapy
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
neoadjuvant chemotherapy
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
neoadjuvant chemotherapy
condition in which food moves too quickly from the stomach to the small intestine
neoadjuvant chemotherapy
altered taste
neoadjuvant chemotherapy
difficulty swallowing
neoadjuvant chemotherapy
difficulty speaking
neoadjuvant chemotherapy
an agent that causes nausea and/or vomiting
neoadjuvant chemotherapy
inflammation of a mucous membrane
neoadjuvant chemotherapy
the lowest point
neoadjuvant chemotherapy
refers to chemotherapy used prior to primary treatment
neoadjuvant chemotherapy
low white blood cell count
neoadjuvant chemotherapy
painful swallowing
neoadjuvant chemotherapy
a non-curative treatment which reduces symptoms such as pain
neoadjuvant chemotherapy
a prediction of the probable course and outcome of a disease
neoadjuvant chemotherapy
a pharmacologic agent that promotes gastric emptying
neoadjuvant chemotherapy
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
neoadjuvant chemotherapy
fat malabsorption resulting in severe diarrhea
neoadjuvant chemotherapy
refers to a condition or disease for which there is no cure
neoadjuvant chemotherapy
dry mouth
prognosis
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
prognosis
a measure of the number of neutrophil granulocytes
prognosis
a pharmacologic agent that reduces nausea
prognosis
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
prognosis
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
prognosis
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
prognosis
condition in which food moves too quickly from the stomach to the small intestine
prognosis
altered taste
prognosis
difficulty swallowing
prognosis
difficulty speaking
prognosis
an agent that causes nausea and/or vomiting
prognosis
inflammation of a mucous membrane
prognosis
the lowest point
prognosis
refers to chemotherapy used prior to primary treatment
prognosis
low white blood cell count
prognosis
painful swallowing
prognosis
a non-curative treatment which reduces symptoms such as pain
prognosis
a prediction of the probable course and outcome of a disease
prognosis
a pharmacologic agent that promotes gastric emptying
prognosis
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
prognosis
fat malabsorption resulting in severe diarrhea
prognosis
refers to a condition or disease for which there is no cure
prognosis
dry mouth
Barrett's esophagus
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
Barrett's esophagus
a measure of the number of neutrophil granulocytes
Barrett's esophagus
a pharmacologic agent that reduces nausea
Barrett's esophagus
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
Barrett's esophagus
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
Barrett's esophagus
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
Barrett's esophagus
condition in which food moves too quickly from the stomach to the small intestine
Barrett's esophagus
altered taste
Barrett's esophagus
difficulty swallowing
Barrett's esophagus
difficulty speaking
Barrett's esophagus
an agent that causes nausea and/or vomiting
Barrett's esophagus
inflammation of a mucous membrane
Barrett's esophagus
the lowest point
Barrett's esophagus
refers to chemotherapy used prior to primary treatment
Barrett's esophagus
low white blood cell count
Barrett's esophagus
painful swallowing
Barrett's esophagus
a non-curative treatment which reduces symptoms such as pain
Barrett's esophagus
a prediction of the probable course and outcome of a disease
Barrett's esophagus
a pharmacologic agent that promotes gastric emptying
Barrett's esophagus
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
Barrett's esophagus
fat malabsorption resulting in severe diarrhea
Barrett's esophagus
refers to a condition or disease for which there is no cure
Barrett's esophagus
dry mouth
mucositis
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
mucositis
a measure of the number of neutrophil granulocytes
mucositis
a pharmacologic agent that reduces nausea
mucositis
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
mucositis
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
mucositis
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
mucositis
condition in which food moves too quickly from the stomach to the small intestine
mucositis
altered taste
mucositis
difficulty swallowing
mucositis
difficulty speaking
mucositis
an agent that causes nausea and/or vomiting
mucositis
inflammation of a mucous membrane
mucositis
the lowest point
mucositis
refers to chemotherapy used prior to primary treatment
mucositis
low white blood cell count
mucositis
painful swallowing
mucositis
a non-curative treatment which reduces symptoms such as pain
mucositis
a prediction of the probable course and outcome of a disease
mucositis
a pharmacologic agent that promotes gastric emptying
mucositis
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
mucositis
fat malabsorption resulting in severe diarrhea
mucositis
refers to a condition or disease for which there is no cure
mucositis
dry mouth
prokinetic
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
prokinetic
a measure of the number of neutrophil granulocytes
prokinetic
a pharmacologic agent that reduces nausea
prokinetic
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
prokinetic
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
prokinetic
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
prokinetic
condition in which food moves too quickly from the stomach to the small intestine
prokinetic
altered taste
prokinetic
difficulty swallowing
prokinetic
difficulty speaking
prokinetic
an agent that causes nausea and/or vomiting
prokinetic
inflammation of a mucous membrane
prokinetic
the lowest point
prokinetic
refers to chemotherapy used prior to primary treatment
prokinetic
low white blood cell count
prokinetic
painful swallowing
prokinetic
a non-curative treatment which reduces symptoms such as pain
prokinetic
a prediction of the probable course and outcome of a disease
prokinetic
a pharmacologic agent that promotes gastric emptying
prokinetic
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
prokinetic
fat malabsorption resulting in severe diarrhea
prokinetic
refers to a condition or disease for which there is no cure
prokinetic
dry mouth
brachytherapy
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
brachytherapy
a measure of the number of neutrophil granulocytes
brachytherapy
a pharmacologic agent that reduces nausea
brachytherapy
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
brachytherapy
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
brachytherapy
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
brachytherapy
condition in which food moves too quickly from the stomach to the small intestine
brachytherapy
altered taste
brachytherapy
difficulty swallowing
brachytherapy
difficulty speaking
brachytherapy
an agent that causes nausea and/or vomiting
brachytherapy
inflammation of a mucous membrane
brachytherapy
the lowest point
brachytherapy
refers to chemotherapy used prior to primary treatment
brachytherapy
low white blood cell count
brachytherapy
painful swallowing
brachytherapy
a non-curative treatment which reduces symptoms such as pain
brachytherapy
a prediction of the probable course and outcome of a disease
brachytherapy
a pharmacologic agent that promotes gastric emptying
brachytherapy
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
brachytherapy
fat malabsorption resulting in severe diarrhea
brachytherapy
refers to a condition or disease for which there is no cure
brachytherapy
dry mouth
combination chemotherapy
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
combination chemotherapy
a measure of the number of neutrophil granulocytes
combination chemotherapy
a pharmacologic agent that reduces nausea
combination chemotherapy
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
combination chemotherapy
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
combination chemotherapy
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
combination chemotherapy
condition in which food moves too quickly from the stomach to the small intestine
combination chemotherapy
altered taste
combination chemotherapy
difficulty swallowing
combination chemotherapy
difficulty speaking
combination chemotherapy
an agent that causes nausea and/or vomiting
combination chemotherapy
inflammation of a mucous membrane
combination chemotherapy
the lowest point
combination chemotherapy
refers to chemotherapy used prior to primary treatment
combination chemotherapy
low white blood cell count
combination chemotherapy
painful swallowing
combination chemotherapy
a non-curative treatment which reduces symptoms such as pain
combination chemotherapy
a prediction of the probable course and outcome of a disease
combination chemotherapy
a pharmacologic agent that promotes gastric emptying
combination chemotherapy
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
combination chemotherapy
fat malabsorption resulting in severe diarrhea
combination chemotherapy
refers to a condition or disease for which there is no cure
combination chemotherapy
dry mouth
antiemetic
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
antiemetic
a measure of the number of neutrophil granulocytes
antiemetic
a pharmacologic agent that reduces nausea
antiemetic
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
antiemetic
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
antiemetic
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
antiemetic
condition in which food moves too quickly from the stomach to the small intestine
antiemetic
altered taste
antiemetic
difficulty swallowing
antiemetic
difficulty speaking
antiemetic
an agent that causes nausea and/or vomiting
antiemetic
inflammation of a mucous membrane
antiemetic
the lowest point
antiemetic
refers to chemotherapy used prior to primary treatment
antiemetic
low white blood cell count
antiemetic
painful swallowing
antiemetic
a non-curative treatment which reduces symptoms such as pain
antiemetic
a prediction of the probable course and outcome of a disease
antiemetic
a pharmacologic agent that promotes gastric emptying
antiemetic
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
antiemetic
fat malabsorption resulting in severe diarrhea
antiemetic
refers to a condition or disease for which there is no cure
antiemetic
dry mouth
terminal
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
terminal
a measure of the number of neutrophil granulocytes
terminal
a pharmacologic agent that reduces nausea
terminal
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
terminal
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
terminal
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
terminal
condition in which food moves too quickly from the stomach to the small intestine
terminal
altered taste
terminal
difficulty swallowing
terminal
difficulty speaking
terminal
an agent that causes nausea and/or vomiting
terminal
inflammation of a mucous membrane
terminal
the lowest point
terminal
refers to chemotherapy used prior to primary treatment
terminal
low white blood cell count
terminal
painful swallowing
terminal
a non-curative treatment which reduces symptoms such as pain
terminal
a prediction of the probable course and outcome of a disease
terminal
a pharmacologic agent that promotes gastric emptying
terminal
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
terminal
fat malabsorption resulting in severe diarrhea
terminal
refers to a condition or disease for which there is no cure
terminal
dry mouth
neutropenia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
neutropenia
a measure of the number of neutrophil granulocytes
neutropenia
a pharmacologic agent that reduces nausea
neutropenia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
neutropenia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
neutropenia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
neutropenia
condition in which food moves too quickly from the stomach to the small intestine
neutropenia
altered taste
neutropenia
difficulty swallowing
neutropenia
difficulty speaking
neutropenia
an agent that causes nausea and/or vomiting
neutropenia
inflammation of a mucous membrane
neutropenia
the lowest point
neutropenia
refers to chemotherapy used prior to primary treatment
neutropenia
low white blood cell count
neutropenia
painful swallowing
neutropenia
a non-curative treatment which reduces symptoms such as pain
neutropenia
a prediction of the probable course and outcome of a disease
neutropenia
a pharmacologic agent that promotes gastric emptying
neutropenia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
neutropenia
fat malabsorption resulting in severe diarrhea
neutropenia
refers to a condition or disease for which there is no cure
neutropenia
dry mouth
palliative
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
palliative
a measure of the number of neutrophil granulocytes
palliative
a pharmacologic agent that reduces nausea
palliative
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
palliative
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
palliative
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
palliative
condition in which food moves too quickly from the stomach to the small intestine
palliative
altered taste
palliative
difficulty swallowing
palliative
difficulty speaking
palliative
an agent that causes nausea and/or vomiting
palliative
inflammation of a mucous membrane
palliative
the lowest point
palliative
refers to chemotherapy used prior to primary treatment
palliative
low white blood cell count
palliative
painful swallowing
palliative
a non-curative treatment which reduces symptoms such as pain
palliative
a prediction of the probable course and outcome of a disease
palliative
a pharmacologic agent that promotes gastric emptying
palliative
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
palliative
fat malabsorption resulting in severe diarrhea
palliative
refers to a condition or disease for which there is no cure
palliative
dry mouth
xerostomia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
xerostomia
a measure of the number of neutrophil granulocytes
xerostomia
a pharmacologic agent that reduces nausea
xerostomia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
xerostomia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
xerostomia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
xerostomia
condition in which food moves too quickly from the stomach to the small intestine
xerostomia
altered taste
xerostomia
difficulty swallowing
xerostomia
difficulty speaking
xerostomia
an agent that causes nausea and/or vomiting
xerostomia
inflammation of a mucous membrane
xerostomia
the lowest point
xerostomia
refers to chemotherapy used prior to primary treatment
xerostomia
low white blood cell count
xerostomia
painful swallowing
xerostomia
a non-curative treatment which reduces symptoms such as pain
xerostomia
a prediction of the probable course and outcome of a disease
xerostomia
a pharmacologic agent that promotes gastric emptying
xerostomia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
xerostomia
fat malabsorption resulting in severe diarrhea
xerostomia
refers to a condition or disease for which there is no cure
xerostomia
dry mouth
steatorrhea
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
steatorrhea
a measure of the number of neutrophil granulocytes
steatorrhea
a pharmacologic agent that reduces nausea
steatorrhea
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
steatorrhea
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
steatorrhea
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
steatorrhea
condition in which food moves too quickly from the stomach to the small intestine
steatorrhea
altered taste
steatorrhea
difficulty swallowing
steatorrhea
difficulty speaking
steatorrhea
an agent that causes nausea and/or vomiting
steatorrhea
inflammation of a mucous membrane
steatorrhea
the lowest point
steatorrhea
refers to chemotherapy used prior to primary treatment
steatorrhea
low white blood cell count
steatorrhea
painful swallowing
steatorrhea
a non-curative treatment which reduces symptoms such as pain
steatorrhea
a prediction of the probable course and outcome of a disease
steatorrhea
a pharmacologic agent that promotes gastric emptying
steatorrhea
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
steatorrhea
fat malabsorption resulting in severe diarrhea
steatorrhea
refers to a condition or disease for which there is no cure
steatorrhea
dry mouth
dumping syndrome
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
dumping syndrome
a measure of the number of neutrophil granulocytes
dumping syndrome
a pharmacologic agent that reduces nausea
dumping syndrome
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
dumping syndrome
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
dumping syndrome
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
dumping syndrome
condition in which food moves too quickly from the stomach to the small intestine
dumping syndrome
altered taste
dumping syndrome
difficulty swallowing
dumping syndrome
difficulty speaking
dumping syndrome
an agent that causes nausea and/or vomiting
dumping syndrome
inflammation of a mucous membrane
dumping syndrome
the lowest point
dumping syndrome
refers to chemotherapy used prior to primary treatment
dumping syndrome
low white blood cell count
dumping syndrome
painful swallowing
dumping syndrome
a non-curative treatment which reduces symptoms such as pain
dumping syndrome
a prediction of the probable course and outcome of a disease
dumping syndrome
a pharmacologic agent that promotes gastric emptying
dumping syndrome
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
dumping syndrome
fat malabsorption resulting in severe diarrhea
dumping syndrome
refers to a condition or disease for which there is no cure
dumping syndrome
dry mouth
dysphonia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
dysphonia
a measure of the number of neutrophil granulocytes
dysphonia
a pharmacologic agent that reduces nausea
dysphonia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
dysphonia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
dysphonia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
dysphonia
condition in which food moves too quickly from the stomach to the small intestine
dysphonia
altered taste
dysphonia
difficulty swallowing
dysphonia
difficulty speaking
dysphonia
an agent that causes nausea and/or vomiting
dysphonia
inflammation of a mucous membrane
dysphonia
the lowest point
dysphonia
refers to chemotherapy used prior to primary treatment
dysphonia
low white blood cell count
dysphonia
painful swallowing
dysphonia
a non-curative treatment which reduces symptoms such as pain
dysphonia
a prediction of the probable course and outcome of a disease
dysphonia
a pharmacologic agent that promotes gastric emptying
dysphonia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
dysphonia
fat malabsorption resulting in severe diarrhea
dysphonia
refers to a condition or disease for which there is no cure
dysphonia
dry mouth
emetogenic
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
emetogenic
a measure of the number of neutrophil granulocytes
emetogenic
a pharmacologic agent that reduces nausea
emetogenic
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
emetogenic
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
emetogenic
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
emetogenic
condition in which food moves too quickly from the stomach to the small intestine
emetogenic
altered taste
emetogenic
difficulty swallowing
emetogenic
difficulty speaking
emetogenic
an agent that causes nausea and/or vomiting
emetogenic
inflammation of a mucous membrane
emetogenic
the lowest point
emetogenic
refers to chemotherapy used prior to primary treatment
emetogenic
low white blood cell count
emetogenic
painful swallowing
emetogenic
a non-curative treatment which reduces symptoms such as pain
emetogenic
a prediction of the probable course and outcome of a disease
emetogenic
a pharmacologic agent that promotes gastric emptying
emetogenic
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
emetogenic
fat malabsorption resulting in severe diarrhea
emetogenic
refers to a condition or disease for which there is no cure
emetogenic
dry mouth
adjuvant chemotherapy
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
adjuvant chemotherapy
a measure of the number of neutrophil granulocytes
adjuvant chemotherapy
a pharmacologic agent that reduces nausea
adjuvant chemotherapy
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
adjuvant chemotherapy
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
adjuvant chemotherapy
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
adjuvant chemotherapy
condition in which food moves too quickly from the stomach to the small intestine
adjuvant chemotherapy
altered taste
adjuvant chemotherapy
difficulty swallowing
adjuvant chemotherapy
difficulty speaking
adjuvant chemotherapy
an agent that causes nausea and/or vomiting
adjuvant chemotherapy
inflammation of a mucous membrane
adjuvant chemotherapy
the lowest point
adjuvant chemotherapy
refers to chemotherapy used prior to primary treatment
adjuvant chemotherapy
low white blood cell count
adjuvant chemotherapy
painful swallowing
adjuvant chemotherapy
a non-curative treatment which reduces symptoms such as pain
adjuvant chemotherapy
a prediction of the probable course and outcome of a disease
adjuvant chemotherapy
a pharmacologic agent that promotes gastric emptying
adjuvant chemotherapy
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
adjuvant chemotherapy
fat malabsorption resulting in severe diarrhea
adjuvant chemotherapy
refers to a condition or disease for which there is no cure
adjuvant chemotherapy
dry mouth
ANC
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
ANC
a measure of the number of neutrophil granulocytes
ANC
a pharmacologic agent that reduces nausea
ANC
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
ANC
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
ANC
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
ANC
condition in which food moves too quickly from the stomach to the small intestine
ANC
altered taste
ANC
difficulty swallowing
ANC
difficulty speaking
ANC
an agent that causes nausea and/or vomiting
ANC
inflammation of a mucous membrane
ANC
the lowest point
ANC
refers to chemotherapy used prior to primary treatment
ANC
low white blood cell count
ANC
painful swallowing
ANC
a non-curative treatment which reduces symptoms such as pain
ANC
a prediction of the probable course and outcome of a disease
ANC
a pharmacologic agent that promotes gastric emptying
ANC
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
ANC
fat malabsorption resulting in severe diarrhea
ANC
refers to a condition or disease for which there is no cure
ANC
dry mouth
nadir
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
nadir
a measure of the number of neutrophil granulocytes
nadir
a pharmacologic agent that reduces nausea
nadir
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
nadir
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
nadir
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
nadir
condition in which food moves too quickly from the stomach to the small intestine
nadir
altered taste
nadir
difficulty swallowing
nadir
difficulty speaking
nadir
an agent that causes nausea and/or vomiting
nadir
inflammation of a mucous membrane
nadir
the lowest point
nadir
refers to chemotherapy used prior to primary treatment
nadir
low white blood cell count
nadir
painful swallowing
nadir
a non-curative treatment which reduces symptoms such as pain
nadir
a prediction of the probable course and outcome of a disease
nadir
a pharmacologic agent that promotes gastric emptying
nadir
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
nadir
fat malabsorption resulting in severe diarrhea
nadir
refers to a condition or disease for which there is no cure
nadir
dry mouth
dysgeusia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
dysgeusia
a measure of the number of neutrophil granulocytes
dysgeusia
a pharmacologic agent that reduces nausea
dysgeusia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
dysgeusia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
dysgeusia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
dysgeusia
condition in which food moves too quickly from the stomach to the small intestine
dysgeusia
altered taste
dysgeusia
difficulty swallowing
dysgeusia
difficulty speaking
dysgeusia
an agent that causes nausea and/or vomiting
dysgeusia
inflammation of a mucous membrane
dysgeusia
the lowest point
dysgeusia
refers to chemotherapy used prior to primary treatment
dysgeusia
low white blood cell count
dysgeusia
painful swallowing
dysgeusia
a non-curative treatment which reduces symptoms such as pain
dysgeusia
a prediction of the probable course and outcome of a disease
dysgeusia
a pharmacologic agent that promotes gastric emptying
dysgeusia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
dysgeusia
fat malabsorption resulting in severe diarrhea
dysgeusia
refers to a condition or disease for which there is no cure
dysgeusia
dry mouth
odynophagia
the use of drugs as additional treatment for patients with cancers that are thought to have spread outside their original sites
odynophagia
a measure of the number of neutrophil granulocytes
odynophagia
a pharmacologic agent that reduces nausea
odynophagia
a complication of severe chronic GERD involving changes in the cells of the tissue that line the bottom of the esophagus
odynophagia
a type of radiation therapy in which radioactive materials are placed in direct contact with the tissue being treated
odynophagia
the use of two or more antineoplastic agents to achieve maximum kill of malignant cells
odynophagia
condition in which food moves too quickly from the stomach to the small intestine
odynophagia
altered taste
odynophagia
difficulty swallowing
odynophagia
difficulty speaking
odynophagia
an agent that causes nausea and/or vomiting
odynophagia
inflammation of a mucous membrane
odynophagia
the lowest point
odynophagia
refers to chemotherapy used prior to primary treatment
odynophagia
low white blood cell count
odynophagia
painful swallowing
odynophagia
a non-curative treatment which reduces symptoms such as pain
odynophagia
a prediction of the probable course and outcome of a disease
odynophagia
a pharmacologic agent that promotes gastric emptying
odynophagia
additional treatment, used in hope of a cure or to prolong life, in a patient with recurrence of a malignancy following initial treatment
odynophagia
fat malabsorption resulting in severe diarrhea
odynophagia
refers to a condition or disease for which there is no cure
odynophagia
dry mouth
Unlock Deck
Unlock for access to all 38 flashcards in this deck.
Unlock Deck
k this deck
locked card icon
Unlock Deck
Unlock for access to all 38 flashcards in this deck.